Vilin Bio Med (NSE:VILINBIO) EBITDA Margin % : 19.58% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vilin Bio Med's EBITDA for the six months ended in Sep. 2023 was ₹14.97 Mil. Vilin Bio Med's Revenue for the six months ended in Sep. 2023 was ₹76.46 Mil. Therefore, Vilin Bio Med's EBITDA margin for the quarter that ended in Sep. 2023 was 19.58%.

Vilin Bio Med EBITDA Margin % Historical Data

The historical data trend for Vilin Bio Med's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med EBITDA Margin % Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

EBITDA Margin %

5.27

7.11

6.77

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
EBITDA Margin %	-	-	-	26.96	19.58

Competitive Comparison of Vilin Bio Med's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's EBITDA Margin % falls into.

Vilin Bio Med EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Vilin Bio Med's EBITDA Margin % for the fiscal year that ended in Mar. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Mar. 2022 )	/	Revenue (A: Mar. 2022 )
	=	7.59	/	112.149
	=	6.77 %

Vilin Bio Med's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	14.97	/	76.457
	=	19.58 %

Vilin Bio Med (NSE:VILINBIO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Vilin Bio Med EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » EBITDA Margin %

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines